EGFR gene copy number as a predictive biomarker for the treatment of metastatic colorectal cancer with anti-EGFR monoclonal antibodies: a meta-analysis

BACKGROUND: Epidermal growth factor receptor gene copy number (EGFR GCN) has been heavily investigated as a potential predictive biomarker for the treatment of metastatic colorectal cancer (mCRC) with anti-EGFR monoclonal antibodies (MAbs). The objective of this study was to systematically review cu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zu-Yao, Shen, Wei-Xi, Hu, Xue-Feng, Zheng, Da-Yong, Wu, Xin-Yin, Huang, Ya-Fang, Chen, Jin-Zhang, Mao, Chen, Tang, Jin-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447654/
https://www.ncbi.nlm.nih.gov/pubmed/22897982
http://dx.doi.org/10.1186/1756-8722-5-52

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447654/
https://www.ncbi.nlm.nih.gov/pubmed/22897982
http://dx.doi.org/10.1186/1756-8722-5-52

Ejemplares similares